Amneal (AMRX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.30
- EPS estimate
- $0.22
- EPS surprise
- +34.83%
- Revenue surprise
- +3.64%
- Revenue
- $796.2M
- Revenue estimate
- $768.2M
- Reported
- Jul 30, 2026
Amneal reported Q2 2026 results on July 30, 2026. Earnings per share were $0.30, beating the $0.22 estimate by 34.83%. Revenue was $796.2 million, 3.64% above the $768.2 million consensus. Compared with Q2 2025, EPS rose 20% from $0.25 and revenue grew about 10% from $724.5 million.
Revenue has grown steadily over the table. Annual sales rose from about $2.21 billion in 2022 to $3.02 billion in 2025, an increase of about 37%, and Q4 2025 set the quarterly high at $814.3 million. Earnings were flatter for a time: annual EPS went from $0.68 in 2022 to $0.64 in 2023 and $0.58 in 2024, then rose about 45% to $0.84 in 2025. Q2 2026's $0.30 is the highest quarterly EPS shown. Amneal beat the EPS estimate in 16 of the last 20 quarters, including the last six in a row, and the table does not include a row for Q4 2021.
Amneal reported Q3 between October 30 and November 8 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year gains in earnings and revenue continue into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $0.22 | $0.30 | +34.83% | $796.2M | SEC |
| Q1 2026 | Apr 22, 2026 | $0.17 | $0.27 | +59.67% | $722.5M | SEC |
| Q4 2025 | Feb 27, 2026 | $0.18 | $0.21 | +14.07% | $814.3M | SEC |
| Q3 2025 | Oct 30, 2025 | $0.14 | $0.17 | +22.92% | $784.5M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.18 | $0.25 | +42.86% | $724.5M | SEC |
| Q1 2025 | May 2, 2025 | $0.15 | $0.21 | +43.15% | $695.4M | SEC |
| Q4 2024 | Feb 28, 2025 | $0.15 | $0.12 | −21.31% | $730.5M | SEC |
| Q3 2024 | Nov 8, 2024 | $0.13 | $0.16 | +19.05% | $702.5M | SEC |
| Q2 2024 | Aug 9, 2024 | $0.15 | $0.16 | +8.47% | $701.8M | SEC |
| Q1 2024 | May 3, 2024 | $0.09 | $0.14 | +52.01% | $659.2M | SEC |
| Q4 2023 | Mar 1, 2024 | $0.09 | $0.14 | +55.21% | $617.0M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.13 | $0.19 | +49.84% | $620.0M | SEC |
| Q2 2023 | Aug 4, 2023 | $0.10 | $0.19 | +91.92% | $599.0M | SEC |
| Q1 2023 | May 5, 2023 | $0.10 | $0.12 | +25.00% | $557.5M | SEC |
| Q4 2022 | Mar 2, 2023 | $0.21 | $0.23 | +10.52% | $609.8M | SEC |
| Q3 2022 | Nov 4, 2022 | $0.18 | $0.14 | −20.86% | $545.6M | SEC |
| Q2 2022 | Aug 5, 2022 | $0.19 | $0.19 | −2.26% | $559.4M | SEC |
| Q1 2022 | May 4, 2022 | $0.13 | $0.12 | −6.69% | $497.6M | SEC |
| Q3 2021 | Nov 3, 2021 | $0.20 | $0.21 | +2.79% | $528.6M | SEC |
| Q2 2021 | Aug 9, 2021 | $0.18 | $0.25 | +36.02% | $535.1M | SEC |
Quarterly revenue
Frequently asked questions
When did Amneal (AMRX) last report earnings?
Amneal last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did AMRX beat earnings estimates?
Yes. Amneal reported EPS of $0.30 for Q2 2026 against a $0.22 estimate — a 34.83% beat.
How much revenue did AMRX report last quarter?
Amneal reported $796.2M in revenue for Q2 2026, against a consensus estimate of $768.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.